University of Chicago Medical Center
Chicago, Illinois, 60637, United States
NCT Number: NCT02205801
We aim to study the effect of local anesthetic when used in conjunction with general anesthesia during thyroidectomy or parathyroidectomy. We hypothesize there is equivalent pain control between bilateral superficial cervical plexus block and local wound infiltration when used in conjunction with a general anesthetic.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy.
0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy.
Time frame: During the procedure
The total amount of Fentanyl administered during the procedure will be recorded.
Time frame: At four hour after operation
Pain scores will either be verbally reported to nursing and recorded or reported on a questionnaire. Back of neck pain scores range 0-10, throat pain scores range 0-9, incisional pain scores range 0-9 (zero means no pain and 9 or 10 means severe pain).
Time frame: At 2 weeks after operation
Nausea scores will either be verbally reported to nursing and recorded or reported on a questionnaire. The scores range 0-9 (zero means no symptom and 9 means "very severe").
Time frame: At follow up appointment 1-2 weeks postoperatively
Total operative opioid dosages administered converted to effective mg of Hydromorphine.
University of Chicago
Other
A Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Thyroidectomy and Parathyroidectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00615537
Endocrine Gland Neoplasms, Endocrine System Diseases
Providence, Rhode Island, United States
View Trial DetailsNCT02208544
Endocrine Gland Neoplasms, Endocrine System Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT03469310
Agnosia, Chemically-Induced Disorders
Edinburg, Texas, United States
View Trial DetailsNCT03031639
Endocrine Gland Neoplasms, Endocrine System Diseases
Muang, Khonkaen, Thailand
View Trial Details